Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
The Journal of Infectious Diseases
|
May 10, 2022
Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
Hana M El Sahly, Lindsey R Baden, Brandon Essink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 15, 2023
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus
Scott L Letendre, Huichao Chen, Ashley McKhann, et al.
The Journal of Infectious Diseases
|
August 13, 2021
Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study
Daniel B Horton, Emily S Barrett, Jason Roy, et al.
Open Forum Infectious Diseases
|
October 27, 2025
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 Weeks
Jonathan C Reed, Luke Hall, Ashley McKhann, et al.
Journal of Clinical Microbiology
|
May 6, 2020
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
Michael J Loeffelholz, David Alland, Susan M Butler-Wu, et al.
Emerging Infectious Diseases
|
January 25, 2024
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021
Jessica Justman, Timothy Skalland, Ayana Moore, et al.
Annals of Internal Medicine
|
August 23, 2017
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial
Roy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2026
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study
Raphael J Landovitz, Yvett Pinedo, Federico Hinestrosa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 25, 2020
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
Susan A Olender, Katherine K Perez, Alan S Go, et al.
The New England Journal of Medicine
|
August 11, 2021
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
Raphael J Landovitz, Deborah Donnell, Meredith E Clement, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
The Journal of Infectious Diseases
|
May 10, 2022
Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
Hana M El Sahly, Lindsey R Baden, Brandon Essink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 15, 2023
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus
Scott L Letendre, Huichao Chen, Ashley McKhann, et al.
The Journal of Infectious Diseases
|
August 13, 2021
Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study
Daniel B Horton, Emily S Barrett, Jason Roy, et al.
Open Forum Infectious Diseases
|
October 27, 2025
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 Weeks
Jonathan C Reed, Luke Hall, Ashley McKhann, et al.
Journal of Clinical Microbiology
|
May 6, 2020
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
Michael J Loeffelholz, David Alland, Susan M Butler-Wu, et al.
Emerging Infectious Diseases
|
January 25, 2024
Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021
Jessica Justman, Timothy Skalland, Ayana Moore, et al.
Annals of Internal Medicine
|
August 23, 2017
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial
Roy M Gulick, Timothy J Wilkin, Ying Q Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2026
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study
Raphael J Landovitz, Yvett Pinedo, Federico Hinestrosa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 25, 2020
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
Susan A Olender, Katherine K Perez, Alan S Go, et al.
The New England Journal of Medicine
|
August 11, 2021
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
Raphael J Landovitz, Deborah Donnell, Meredith E Clement, et al.
Page
of 4